The significance of MEMO1 in cancer is underscored by its overexpression across multiple malignancies, such as breast, colon, lung, and uterine cancers, as evidenced by analyses of the Cancer Genome Atlas database (https://www.cancer.gov/tcga, accessed on 18 January 2024). Here, MEMO1 is linked to cancer.